149 related articles for article (PubMed ID: 37844021)
1. Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
Shang F; Liu X; Ren X; Li Y; Cai L; Sun Y; Wen J; Zhai X
PLoS One; 2023; 18(10):e0292488. PubMed ID: 37844021
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis.
Cao ZX; Weng X; Huang JS; Long X
Updates Surg; 2022 Oct; 74(5):1551-1562. PubMed ID: 35821560
[TBL] [Abstract][Full Text] [Related]
4. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
9. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract][Full Text] [Related]
10. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant external beam radiation for medullary thyroid carcinoma.
Martinez SR; Beal SH; Chen A; Chen SL; Schneider PD
J Surg Oncol; 2010 Aug; 102(2):175-8. PubMed ID: 20648590
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system.
Machens A; Dralle H
Ann Surg; 2013 Feb; 257(2):323-9. PubMed ID: 22968075
[TBL] [Abstract][Full Text] [Related]
14. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H
Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769
[TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract][Full Text] [Related]
16. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
17. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
18. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
19. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
20. Lymph node yield as a prognostic factor in cancer studies--due to undersampling of tumor-free lymph nodes at higher N stages?
Metze K
Ann Surg Oncol; 2009 Apr; 16(4):1080-2; author reply 1083. PubMed ID: 18787904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
